A review of Lassa fever vaccine candidates

This publication has 27 references indexed in Scilit:

• VaxCelerate II: Rapid development of a self-assembling vaccine for Lassa fever
  Human Vaccines & Immunotherapeutics, 2014
• An attenuated Lassa vaccine in SIV-infected rhesus macaques does not persist or cause arenavirus disease but does elicit Lassa virus-specific immunity
  Virology Journal, 2013
• Advanced Vaccine Candidates for Lassa Fever
  Viruses, 2012
• Shedding of soluble glycoprotein 1 detected during acute Lassa virus infection in human subjects
  Virology Journal, 2010
• A Multivalent Vaccination Strategy for the Prevention of Old World Arenavirus Infection in Humans
  Journal of Virology, 2010
• A Multivalent and Cross-Protective Vaccine Strategy against Arenaviruses Associated with Human Disease
  PLOS Pathogens, 2009
• Marker gene swapping facilitates recombinant Modified Vaccinia Virus Ankara production by host-range selection
  Journal of Virological Methods, 2009
• A ML29 reassortant virus protects guinea pigs against a distantly related Nigerian strain of Lassa virus and can provide sterilizing immunity
  Vaccine, 2007
• A recombinant Yellow Fever 17D vaccine expressing Lassa virus glycoproteins
  Virology, 2006
• Individual and Bivalent Vaccines Based on Alphavirus Replicons Protect Guinea Pigs against Infection with Lassa and Ebola Viruses
  Journal of Virology, 2001